Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More

Luminex® Blog

The Faces of Luminex: Jen Dillman, Product Development

There are a lot of steps between having the idea for a new product and actually making the product for commercial release. Here at Luminex, we count on people like Jen Dillman, Senior Manager of Product Development, to help get new products across the finish line.

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

Innovative flow technologies are advancing cellular analysis. Dr. Alan Tunnicliffe-Bruens will be on site at…
h J R
RT @Luminex: He's published more #xMAP papers than any other user, and he's ready to share what he's learned with YOU! Check out these fun…
h J R
RT @Luminex: From horse cloning to custom assay development, @TAMU animal science graduate Heather Darby has had an interesting path to Lum…
h J R

Latest News

March 5
Luminex Corporation to Present at the Barclays Global Healthcare Conference

February 8
Luminex Corporation Declares First Quarter Cash Dividend

February 4
Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results

January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio

November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results


13-16 April
Amsterdam, Netherlands

Oxford Immunology Symposium
23-24 April
Oxford, UK

12th Annual Proteins & Antibodies Congress
24-25 April
London, UK